FAQ/Help |
Calendar |
Search |
Today's Posts |
|
Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
Reply |
|
Thread Tools | Display Modes |
12-14-2010, 10:13 AM | #1 | ||
|
|||
Member
|
Sangamo BioSciences Announces Publication of Data From Program to Develop a ZFP Therapeutic® for Parkinson's Disease
Dec. 13, 2010 /PRNewswire http://www.prnewswire.com/news-relea...111776389.html Produce GDNF "We are enthusiastic about the success of this novel ZFP Therapeutic approach to date and hopeful that its further development can take us closer to our goal of delivering Parkinson's patients better treatment options," said Todd Sherer, Ph.D., Chief Program Officer at MJFF. Last edited by CarolynS; 12-14-2010 at 10:29 AM. |
||
Reply With Quote |
"Thanks for this!" says: | VICTORIALOU (12-29-2010) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Rexahn Pharmaceuticals Announces Publication of Study on Neuroprotective Effects of C | Parkinson's Disease | |||
Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lat | ALS News & Research | |||
Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for | ALS News & Research | |||
The ALS Association Announces $ 3.5 Million Partnership with Cambria Biosciences to A | ALS News & Research | |||
Safinamide..Merck Serono Announces 18-Month Safety and Efficacy Data Phase III Trial | Parkinson's Disease Clinical Trials |